Replies to post #22893 on Humanigen Inc (HGENQ)

[ohm20]

Did you want me to look at the one that most closely resembles the primary endpoint of the phase 3 trial? That doesn't look good.

Incidence of clinical improvement lenzilumab group - 11 (92%) control group 22 (81%) p = .43